{"name":"Genfleet Therapeutics (Shanghai) Inc.","slug":"genfleet-therapeutics-shanghai-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GFH375","genericName":"GFH375","slug":"gfh375","indication":"Moderate to severe ulcerative colitis","status":"phase_3"}]}],"pipeline":[{"name":"GFH375","genericName":"GFH375","slug":"gfh375","phase":"phase_3","mechanism":"GFH375 is a small molecule inhibitor of the PI3K delta subunit.","indications":["Moderate to severe ulcerative colitis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPLTY2dnAyUXFQUnQ3NkwyWE1Fd01TZnZfZnRGSVN0cHhDaEd5MnJQZjJwQUtZa0FBd1VCT0NyTXpiZ3hKbGJBT3c1V3A1N0lVa01NemR1ZzA0ODJCZ1pNZ1lWTV9jd2hFYW4wdWJmbmJuLU1OZGNrOU92d3pHX2czM2FteWVZS3JDS3FtYlRWMExNbjdPQnp3eGpVYzcxR3FJd2RWeUZn?oc=5","date":"2025-12-09","type":"pipeline","source":"BioCentury","summary":"Up next for KRAS: An advancing wave of G12D-targeting programs - BioCentury","headline":"Up next for KRAS: An advancing wave of G12D-targeting programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPYkUtWU5iZnpoMlFnNWJSSTVSMG5qVGRITzV3NWVscUR2MDBwQVFrUnYzWHJCVC1qT0g4V3VtOGlvanB4a25sMThsQVdEN0pnUEtNcU9qcFRuSEZubUtoVDI2aVc5UlRVTjFkNFlxYWY3Sld2UFltZGs0dVJJakpIb290cWNFVTg?oc=5","date":"2025-09-23","type":"pipeline","source":"BioWorld News","summary":"Genfleet raises $234M with Hong Kong IPO - BioWorld News","headline":"Genfleet raises $234M with Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQRmdITkIzU1l0cTZ1VjZreGFMS19VLUxPOFdLLW9xeWdxMkIzaEg3VnJJSEk3SzBsSFNibUxSWTlpM1ZRcWthNllUT1d0OVBnd1lUUG85RkdUOWlrQWJIMHNyVElvVi1MUlNmczJNNUpZSV9QSlNQS3BCREVhYS1LS01nRUhESk9Ic0lLOGdkOHN2QjRHZlRESVdnbTdjbHdlTURz?oc=5","date":"2025-07-24","type":"pipeline","source":"BioWorld News","summary":"34 mainland China biotechs file for Hong Kong IPO in H1 2025 - BioWorld News","headline":"34 mainland China biotechs file for Hong Kong IPO in H1 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTFFwdXZEb2ZtWFQ4WXVSQnZYcE1YRzAzVGlxazUyR2k4eGkxMk95eUotQUphaUp4OEVWektzRXU4V2tNR1l1NVVwWXpaLWxKdVBpdndSQTlpSmdnbnB6Yjg5QXUtY2c3TTEwZ3l5aUJjcVBNUDludTl2X25HX3VhZmVKMndlOFBk?oc=5","date":"2025-01-09","type":"pipeline","source":"thebambooworks.com","summary":"Cancer drug maker Genfleet joins Hong Kong IPO influx - thebambooworks.com","headline":"Cancer drug maker Genfleet joins Hong Kong IPO influx","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}